These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32577431)

  • 1. rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates.
    Ishii A; Okada H; Hayashita-Kinoh H; Shin JH; Tamaoka A; Okada T; Takeda S
    Mol Ther Methods Clin Dev; 2020 Sep; 18():44-49. PubMed ID: 32577431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle.
    Ohshima S; Shin JH; Yuasa K; Nishiyama A; Kira J; Okada T; Takeda S
    Mol Ther; 2009 Jan; 17(1):73-80. PubMed ID: 18941441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
    Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
    Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy.
    Okada T; Takeda S
    Pharmaceuticals (Basel); 2013 Jun; 6(7):813-36. PubMed ID: 24276316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog.
    Koo T; Okada T; Athanasopoulos T; Foster H; Takeda S; Dickson G
    J Gene Med; 2011 Sep; 13(9):497-506. PubMed ID: 22144143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.
    Yoshimura M; Sakamoto M; Ikemoto M; Mochizuki Y; Yuasa K; Miyagoe-Suzuki Y; Takeda S
    Mol Ther; 2004 Nov; 10(5):821-8. PubMed ID: 15509500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and long-term monitoring of humoral immunity against adeno-associated virus in Duchenne Muscular Dystrophy patients.
    Leborgne C; Latournerie V; Boutin S; Desgue D; Quéré A; Pignot E; Collaud F; Charles S; Simon Sola M; Masat E; Jouen F; Boyer O; Masurier C; Mingozzi F; Veron P
    Cell Immunol; 2019 Aug; 342():103780. PubMed ID: 29571923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
    Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
    Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
    Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene therapy for muscular dystrophy].
    Takeda S
    No To Hattatsu; 2004 Mar; 36(2):117-23. PubMed ID: 15031985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle.
    Ghosh A; Yue Y; Duan D
    J Gene Med; 2006 Mar; 8(3):298-305. PubMed ID: 16385549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment.
    Hayashita-Kinoh H; Guillermo PH; Nitahara-Kasahara Y; Kuraoka M; Okada H; Chiyo T; Takeda S; Okada T
    Mol Ther Methods Clin Dev; 2021 Mar; 20():133-141. PubMed ID: 33426145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status and perspective of gene therapy on dystrophic animal model].
    Takeda S
    Rinsho Shinkeigaku; 2004 Nov; 44(11):911-3. PubMed ID: 15651329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.
    Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G
    Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction.
    Shin JH; Nitahara-Kasahara Y; Hayashita-Kinoh H; Ohshima-Hosoyama S; Kinoshita K; Chiyo T; Okada H; Okada T; Takeda S
    Gene Ther; 2011 Sep; 18(9):910-9. PubMed ID: 21451578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.
    Inagaki K; Fuess S; Storm TA; Gibson GA; Mctiernan CF; Kay MA; Nakai H
    Mol Ther; 2006 Jul; 14(1):45-53. PubMed ID: 16713360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
    Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
    Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element.
    Wang L; Wang Z; Zhang F; Zhu R; Bi J; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
    Int J Med Sci; 2016; 13(4):286-91. PubMed ID: 27076785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
    Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
    Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Serum rAAV Serotype-Specific Antibodies in Patients with Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Inclusion Body Myositis, or GNE Myopathy.
    Zygmunt DA; Crowe KE; Flanigan KM; Martin PT
    Hum Gene Ther; 2017 Sep; 28(9):737-746. PubMed ID: 28042944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.